Could a new tracer revolutionize Alzheimer's diagnosis?
NCT ID NCT07306598
First seen Jan 08, 2026 · Last updated Jun 20, 2026 · Updated 26 times
Summary
This study tests a new radioactive tracer called [18F]NIDF for PET scans. The tracer is designed to bind to tau tangles in the brain, which are linked to Alzheimer's and other neurodegenerative diseases. Researchers want to see if it is safe and can produce clearer images than current tracers. The study involves 20 healthy volunteers and patients with Alzheimer's or related conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
RECRUITINGHefei, Anhui, 230000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tianjin Medical University General Hospital
RECRUITINGTianjin, Tianjin Municipality, 350005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F]NIDF (a radioactive tracer for PET imaging)
What this could lead to
If successful, this could lead to a more accurate way to diagnose Alzheimer's and other tau-related brain diseases using PET scans.
What could go wrong
This is a very early, small study (20 people) focused on safety and imaging quality. The tracer may not prove better than existing methods, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.